BR112015024359A2 - micro cápsulas de piperaquina e composições contendo as mesmas - Google Patents

micro cápsulas de piperaquina e composições contendo as mesmas

Info

Publication number
BR112015024359A2
BR112015024359A2 BR112015024359A BR112015024359A BR112015024359A2 BR 112015024359 A2 BR112015024359 A2 BR 112015024359A2 BR 112015024359 A BR112015024359 A BR 112015024359A BR 112015024359 A BR112015024359 A BR 112015024359A BR 112015024359 A2 BR112015024359 A2 BR 112015024359A2
Authority
BR
Brazil
Prior art keywords
piperaquine
same
compositions containing
micro capsules
capsules
Prior art date
Application number
BR112015024359A
Other languages
English (en)
Other versions
BR112015024359B1 (pt
Inventor
Stollberg Christian
Fabiani Flavio
Bianchi Giancarla
Boltri Luigi
Original Assignee
Adare Pharmaceuticals S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adare Pharmaceuticals S R L filed Critical Adare Pharmaceuticals S R L
Publication of BR112015024359A2 publication Critical patent/BR112015024359A2/pt
Publication of BR112015024359B1 publication Critical patent/BR112015024359B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
BR112015024359-2A 2013-03-22 2014-03-21 Microcápsulas de piperaquina e composições contendo o mesmo BR112015024359B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361804448P 2013-03-22 2013-03-22
US61/804,448 2013-03-22
PCT/EP2014/055747 WO2014147242A1 (en) 2013-03-22 2014-03-21 Piperaquine microcapsules and compositions containing them

Publications (2)

Publication Number Publication Date
BR112015024359A2 true BR112015024359A2 (pt) 2017-07-18
BR112015024359B1 BR112015024359B1 (pt) 2022-09-13

Family

ID=51789429

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015024359-2A BR112015024359B1 (pt) 2013-03-22 2014-03-21 Microcápsulas de piperaquina e composições contendo o mesmo

Country Status (14)

Country Link
US (2) US20140322296A1 (pt)
EP (1) EP2976069B1 (pt)
JP (1) JP6345762B2 (pt)
KR (1) KR20150133267A (pt)
CN (1) CN105228597B (pt)
AU (1) AU2014234258B2 (pt)
BR (1) BR112015024359B1 (pt)
CA (1) CA2907628C (pt)
ES (1) ES2809254T3 (pt)
MX (1) MX354453B (pt)
PL (1) PL2976069T3 (pt)
PT (1) PT2976069T (pt)
SG (2) SG10201706609XA (pt)
WO (1) WO2014147242A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104814931B (zh) * 2015-04-14 2017-12-26 华南农业大学 一种喹乙醇缓释颗粒及其制备方法和应用
US20180256515A1 (en) 2017-03-10 2018-09-13 Adare Pharmaceuticals, Inc. Oral amphetamine composition
CN114343230B (zh) * 2022-02-10 2023-05-12 湖北中烟工业有限责任公司 一种薄片添加剂、其制备方法及含有该薄片添加剂的烟草薄片

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
HUE033191T2 (en) * 2005-05-18 2017-11-28 Sun Pharmaceutical Ind Ltd Stable dosage forms of spiro and dispiro-1,2,4-trioxolane anti-malarial agents
TWI547282B (zh) * 2007-07-02 2016-09-01 愛戴爾製藥股份有限公司 樂命達之口服分解錠劑組合物
EP2506836B1 (en) * 2009-12-02 2018-02-14 Adare Pharmaceuticals S.R.L. Fexofenadine microcapsules and compositions containing them

Also Published As

Publication number Publication date
WO2014147242A1 (en) 2014-09-25
ES2809254T3 (es) 2021-03-03
CN105228597B (zh) 2019-03-26
PL2976069T3 (pl) 2020-10-19
MX354453B (es) 2018-03-05
SG10201706609XA (en) 2017-09-28
BR112015024359B1 (pt) 2022-09-13
US20160045447A1 (en) 2016-02-18
AU2014234258B2 (en) 2019-02-14
AU2014234258A1 (en) 2015-10-08
WO2014147242A8 (en) 2015-11-05
JP6345762B2 (ja) 2018-06-20
CA2907628A1 (en) 2014-09-25
CA2907628C (en) 2021-11-16
CN105228597A (zh) 2016-01-06
MX2015013470A (es) 2016-06-02
KR20150133267A (ko) 2015-11-27
US20140322296A1 (en) 2014-10-30
US9668979B2 (en) 2017-06-06
SG11201507843TA (en) 2015-10-29
EP2976069B1 (en) 2020-05-06
JP2016514720A (ja) 2016-05-23
PT2976069T (pt) 2020-08-05
EP2976069A1 (en) 2016-01-27

Similar Documents

Publication Publication Date Title
BR112015003354A2 (pt) composições e métodos de microcápsula
RU2016118771A3 (en) Co-crystals and pharmaceutical compositions comprising the same
GB201303690D0 (en) Microcapsules and contrete containing the same
DOS2013000177S (es) Capsulas
BR302012004210S1 (pt) Configuracao aplicada à cápsula
DK2956410T3 (da) Kompositsilicium- eller komposittinpartikler
BR302012004214S1 (pt) Configuracao aplicada à cápsula
CL2015002389A1 (es) Composiciones herbicidas que contienen isoxabena y flufenaceto.
BR112015024359A2 (pt) micro cápsulas de piperaquina e composições contendo as mesmas
FR3005989B1 (fr) Turbopropulseur d'aeronef
ES1092430Y (es) "Anafe paellero"
FR2988729B1 (fr) Compositions de 2,4,4,4-tetrafluorobut-1-ene et de 1-methoxyheptafluoropropane
UA26978S (uk) Орденський знак
SM201300005S1 (it) Ciondoli
UA27219S (uk) Форматор-вулканізатор 75" та 88"
ITTO20130149U1 (it) Guinzaglio di sicurezza
UA29101S (uk) Емблема
UA27910S (uk) Емблема
UA27463S (uk) Емблема
TH1501000622A (th) องค์ประกอบแชมพู
UA27548S (uk) Емблема
ES1078930Y (es) Vitrina de Seguridad
UA25054S (uk) Емблема
UA25052S (uk) Емблема
UA25057S (uk) Емблема

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/03/2014, OBSERVADAS AS CONDICOES LEGAIS